Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

TYBOURNE CAPITAL MANAGEMENT (HK) LTD 13F Holdings -- Portfolio & Top Positions (2025-09-30)

TYBOURNE CAPITAL MANAGEMENT (HK) LTD (CIK 1553936) reported $30.9M across 4 reported positions in its SEC 13F filing for 2025-09-30. Largest positions: TSHA ($12.1M, 39.11%), FBRX ($11.8M, 38.15%), ALMS ($5.6M, 18.05%), ZNTL ($1.5M, 4.69%), BCYC ($0, 0.00%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1TSHATAYSHA GENE THERAPIES INC (TSHA US)$12.1M39.11%3.7MTrimmed
2FBRXFORTE BIOSCIENCES INC (FBRX US)$11.8M38.15%786,647Hold
3ALMSALUMIS INC (ALMS US)$5.6M18.05%1.4MHold
4ZNTLZENTALIS PHARMACEUTICALS INC (ZNTL US)$1.5M4.69%961,486Trimmed
5BCYCBICYCLE THERAPEUTICS LTD-ADR (BCYC US)$00.00%0Exited
6MBUUMALIBU BOATS INC (MBUU US)$00.00%0Exited

Source: SEC Form 13F filings · as of 2025-09-30